STOCK TITAN

Tenon Medical (TNON) director settles 64,479 RSUs into stock

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tenon Medical director Richard Ferrari converted 64,479 restricted stock units into 64,479 shares of common stock on July 31, 2026. Each unit represented a contingent right to receive one share. After this settlement, he directly owned 135,243 shares of Tenon Medical common stock.

Positive

  • None.

Negative

  • None.
Insider Ferrari Richard
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F2 64,479 $0.00 $0.00
Exercise Common Stock F1 64,479 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 135,243 shares (Direct)
Footnotes (2)
  1. F1. Represents conversion of 64,479 restricted stock units granted to the reporting person on October 13, 2025 into 64,479 shares of common stock of the Issuer on July 31, 2026.
  2. F2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
RSUs converted 64,479 units Restricted stock units converted to common stock on July 31, 2026
Shares acquired from conversion 64,479 shares Common stock received from RSU conversion on July 31, 2026
Shares owned after transaction 135,243 shares Direct Tenon Medical common stock holdings of Richard Ferrari after the RSU settlement
Exercise price per share $0.0000 Reported transaction price per share for both RSU conversion and share acquisition
RSU grant date October 13, 2025 Grant date of the 64,479 restricted stock units that later converted
Conversion date July 31, 2026 Date RSUs converted into common stock as reported in the Form 4
Restricted Stock Units financial
"Represents conversion of 64,479 restricted stock units granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of common stock"
derivative security financial
"Transaction code description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Tenon Medical (TNON) report in this Form 4?

Tenon Medical reported that director Richard Ferrari converted 64,479 restricted stock units into 64,479 shares of common stock on July 31, 2026. The transaction is described as an exercise or conversion of a derivative security, not an open-market purchase or sale.

How many Tenon Medical (TNON) shares does Richard Ferrari hold after the transaction?

Following the reported RSU conversion, Richard Ferrari directly holds 135,243 shares of Tenon Medical common stock. This post-transaction balance reflects the addition of 64,479 shares received from the settlement of restricted stock units reported in the Form 4.

What exactly was converted in Richard Ferrari’s Tenon Medical (TNON) Form 4 filing?

The filing shows the conversion of 64,479 restricted stock units into 64,479 shares of common stock. Footnotes state that each restricted stock unit represented a contingent right to receive one share of Tenon Medical common stock upon settlement on July 31, 2026.

Did Richard Ferrari buy or sell Tenon Medical (TNON) stock on the market?

The Form 4 reports an exercise or conversion of derivative securities, not an open-market trade. Restricted stock units converted into common shares at a reported price of $0.00 per share, so the change in holdings came from equity compensation settlement rather than a market purchase or sale.

When were the Tenon Medical (TNON) restricted stock units originally granted to Richard Ferrari?

Footnotes state that the 64,479 restricted stock units were granted to Richard Ferrari on October 13, 2025. These units subsequently converted into an equal number of Tenon Medical common shares on July 31, 2026, as reflected in the current Form 4 filing.

What does each restricted stock unit represent in the Tenon Medical (TNON) filing?

According to the footnotes, each restricted stock unit represents a contingent right to receive one share of Tenon Medical common stock. Upon settlement, these units convert on a one-for-one basis into common shares credited to the reporting person’s direct holdings.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ferrari Richard

(Last)(First)(Middle)
104 COOPER COURT

(Street)
LOS GATOS CALIFORNIA 95032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)07/31/2026M64,479A$0135,243D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)(2)07/31/2026M64,479 (1) (1)Common Stock64,479$00D
Explanation of Responses:
1. Represents conversion of 64,479 restricted stock units granted to the reporting person on October 13, 2025 into 64,479 shares of common stock of the Issuer on July 31, 2026.
2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
/s/ Richard Ferrari08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)